Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways
Abstract Background In high-grade serous ovarian cancer (HGSOC), intrinsic and/or acquired resistance against platinum-containing chemotherapy is a major obstacle for successful treatment. A low frequency of somatic mutations but frequent epigenetic alterations, including DNA methylation in HGSOC tu...
Main Authors: | Tushar Tomar, Steven de Jong, Nicolette G. Alkema, Rieks L. Hoekman, Gert Jan Meersma, Harry G. Klip, Ate GJ van der Zee, G. Bea A. Wisman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-10-01
|
Series: | Genome Medicine |
Online Access: | http://link.springer.com/article/10.1186/s13073-016-0361-5 |
Similar Items
-
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer
by: Tushar Tomar, et al.
Published: (2017-06-01) -
Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells <it>in vitro </it>and in xenografts: Identification of apoptotic genes as targets for demethylation
by: Xue Hui, et al.
Published: (2007-09-01) -
Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature
by: Salvatore Serravalle, et al.
Published: (2016-01-01) -
Therapeutic effect of TRC105 and decitabine combination in AML xenografts
by: June Baik, et al.
Published: (2020-10-01) -
Epigenetic reprogramming and DNA demethylation
by: Bagci, Hakan
Published: (2014)